UHCs 2026 commercial formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
however, it is generally safe to supplement with for three to six months
Patients who used these versions have reported severe gastroparesis, intestinal blockages, and other gastrointestinal injuries
[DOI] [PubMed] [Google Scholar] Tal-Gan Y., Freeman N
It plays a central part in turning the food you eat into usable energy, in keeping your nerves healthy, and in producing the red blood cells that carry oxygen everywhere it needs to go
Among the drugs will be a life-saving medication to treat leukemia offered for $50 per month